[ English | Bahasa Malaysia ] Today is 14th Jul 2020, 05:21 PM (Last updated: 9th Jul 2020)

Text Red Text Black Text Blue Text Green Text Smaller Text Reset Text Larger

Publication Details
Year :

2014

Journal :

Nazilah Abdul Satar, Kamal Shaik Fakiruddin, Puteri JN . Baharuddin, Moon Nian Lim, Zubaidah Zakaria and Badrul Hisham Yahaya (2014). Inhibition of non-small cell Lung cancer-derived putative cancer stem cell through combination of curcumin and cisplatin. Regenerative Research  3(2): 54-55

Abstract :

The study is designed to investigate the potential of curcumin as drug sensitizer and metastatic inhibitor on specific chemo-resistance lung cancer stem cell (CSC) population. Putative CSCs (CD166+/CD326+) isolated from A549 (Non-Small Cell Lung Cancer / NSCLC) cancer cell line were cultured and maintained in RPMI 1640 complete medium throughout the study period. Our finding showed that treatment of curcumin together with cisplatin enhanced apoptosis level of putative CSCs up to ~40% compared to cisplatin treatment alone. Moreover, we noticed that combination of curcumin and cisplatin significantly suppressed the migration of putative CSCs with only ~10% of cells migrated as compared to cisplatin treatment alone (~40%). As a conclusion, we believe that curcumin may enhance the effects of cisplatin on eliminating putative CSCs specific for NSCLC and thus could possibly prevent lung cancer metastasis and recurrence.

myGOV MAMPU JPA IKU MSC NMMR CRC MyHEALTH MOH Globinmed SPA krste.my

Notice

Logo-SIRIM-n-UKAS-IMR

IMR is a SIRIM accredited organisation (certificate number 2972).

This site is best viewed on Firefox (24.0) with resolution higher than 1280 x 768 pixels.

Our Location

world

Located at Jalan Pahang, 50588 Kuala Lumpur, Malaysia. We operate from 8.00am - 5.00pm Monday - Friday. Click on the map image to launch Google Maps service.

Get in touch with us